Genetic Analysis AS (XSAT:GEAN)
0.6400
+0.0100 (1.59%)
At close: Apr 27, 2026
Genetic Analysis AS Market Cap
Genetic Analysis AS has a market cap or net worth of 43.89 million as of April 28, 2026. Its market cap has increased by 34.75% in one year.
Market Cap
43.89M
Enterprise Value
26.39M
Revenue
19.36M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.64
Market Cap Chart
Since October 1, 2021, Genetic Analysis AS's market cap has decreased from 235.48M to 43.89M, a decrease of -81.36%. That is a compound annual growth rate of -30.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 43.89M | -0.89% |
| Dec 30, 2025 | 44.29M | 81.07% |
| Dec 30, 2024 | 24.46M | -31.37% |
| Dec 29, 2023 | 35.64M | -34.69% |
| Dec 30, 2022 | 54.57M | -66.71% |
| Dec 30, 2021 | 163.91M | -30.39% |
| Oct 1, 2021 | 235.48M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AB Igrene | 71.69M |
| Sound Dimension AB | 71.06M |
| QBNK Holding AB | 64.36M |
| MoveByBike Europe AB | 59.03M |
| Kontigo Care AB | 55.70M |
| Redsense Medical AB | 49.17M |
| Touchtech AB | 40.35M |
| EcoRub AB | 39.87M |